NEW YORK (GenomeWeb) – WaferGen Bio-systems announced today that it has signed a deal to work with Roche subsidiary Genentech to evaluate and test its SmartChip platform in single-cell sequencing as part of an early-access program.

WaferGen said the companies will validate the SmartChip technology for isolating single cells from various tissues and preparing libraries for next-generation sequencing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to Stat News, the partial government shutdown in the US could soon affect the ability of the Food and Drug Administration to review new drugs.

Researchers are refining a tool to predict a woman's risk of developing breast cancer, according to the Guardian.

In PNAS this week: gypsy moth genome sequenced, phylogenomic analysis of Polyneopterans, and more.

CNN reports that people's genes tend to have a greater influence on their risk of developing disease than their environment, but it varies by phenotype.